Moderna announced Thursday that the company has asked the Food and Drug Administration to authorize a low-dose version of its COVID-19 vaccine as the first vaccine for children younger than age 5 as the number of new cases continued to rise in Barron County, putting it in risk-level for COVID-19.

In a study involving about 6,700 children, the company said two-doses of the vaccine administered 28 days apart to children ages 6 months to less than 6 years triggered levels of antibodies equivalent to what has protected older children and adults.

(Copyright © 2022 APG Media)

Recommended for you

Load comments